 Siddharth Singh
|
| Title(s) | Assistant Professor Of Clinical, Medicine |
|---|
| School | Vc-health Sciences-schools |
|---|
| Address | 9500 Gilman Drive #
La Jolla CA 92093
|
|---|
| vCard | Download vCard |
|---|
|
|
 Biography | All India Institute of Medical Sciences, New Delhi | MD | 2006 | Medicine | | UCLA and VA Greater Los Angeles Healthcare System | Postdoctoral Scholarship | 2008 | Membrane Biology | | University of Iowa Hospitals and Clinics | Internship | 2009 | Internal Medicine | | University of Iowa Hospitals and Clinics | Residency | 2011 | Internal Medicine | | Mayo Clinic, Rochester | Fellowship | 2014 | Gastroenterology & Hepatology | | Mayo Clinic, Rochester | Advanced Fellowship | 2015 | Inflammatory Bowel Diseases | | Mayo Clinic, Rochester | Master's Degree | 2015 | Clinical and Translational Science |
ORNG Applications Bibliographic
Altmetrics Details
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media.
(Note that publications are often cited in additional ways that are not shown here.)
Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication.
Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication.
Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.)
Click a Field or Translation tag to filter the publications.
-
Risk of Malignancy with Vedolizumab Versus Tumor Necrosis Factor-a Antagonists in Patients with Inflammatory Bowel Diseases. Dig Dis Sci. 2021 Jun 03.
Singh S, Heien HC, Sangaralingham L, Shah ND, Sandborn WJ. PMID: 34085174.
View in: PubMed Mentions: Fields:
-
Comparative Risk of Serious Infections with Tumor Necrosis Factor-a Antagonists vs. Vedolizumab in Patients with Inflammatory Bowel Diseases. Clin Gastroenterol Hepatol. 2021 Feb 25.
Singh S, Heien HC, Herrin J, Dulai PS, Sangaralingham L, Shah ND, Sandborn WJ. PMID: 33640480.
View in: PubMed Mentions: Fields:
-
Management of Inflammatory Bowel Diseases: Clinical Perspectives. Clin Gastroenterol Hepatol. 2020 May; 18(6):1249-1251.
Singh S, Peyrin-Biroulet L, Ananthakrishnan A. PMID: 32057974.
View in: PubMed Mentions: Fields:
-
First- and Second-Line Pharmacotherapies for Patients With Moderate to Severely Active Ulcerative Colitis: An Updated Network Meta-Analysis. Clin Gastroenterol Hepatol. 2020 Sep; 18(10):2179-2191.e6.
Singh S, Murad MH, Fumery M, Dulai PS, Sandborn WJ. PMID: 31945470.
View in: PubMed Mentions: 2 Fields:
-
Management of Inflammatory Bowel Diseases in Special Populations: Obese, Old, or Obstetric. Clin Gastroenterol Hepatol. 2020 May; 18(6):1367-1380.
Singh S, Picardo S, Seow CH. PMID: 31712084.
View in: PubMed Mentions: 1 Fields:
-
Network meta-analysis to inform positioning of biologics in patients with Crohn's disease: Promise and perils. Best Pract Res Clin Gastroenterol. 2019 Feb - Apr; 38-39:101614.
Singh S. PMID: 31327401.
View in: PubMed Mentions: Fields: Translation: Humans
-
Comparative Efficacy and Speed of Onset of Action of Infliximab vs Golimumab in Ulcerative Colitis. Clin Gastroenterol Hepatol. 2020 02; 18(2):424-431.e7.
Singh S, Proudfoot JA, Dulai PS, Xu R, Feagan BG, Sandborn WJ, Jairath V. PMID: 31108227.
View in: PubMed Mentions: 1 Fields:
-
Comparative Risk of Serious Infections With Biologic and/or Immunosuppressive Therapy in Patients With Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis. Clin Gastroenterol Hepatol. 2020 01; 18(1):69-81.e3.
Singh S, Facciorusso A, Dulai PS, Jairath V, Sandborn WJ. PMID: 30876964.
View in: PubMed Mentions: 15 Fields:
-
Evolution of Clinical Trials in Inflammatory Bowel Diseases. Curr Gastroenterol Rep. 2018 Aug 04; 20(9):41.
Singh S. PMID: 30078058.
View in: PubMed Mentions: 1 Fields: Translation: Humans
-
Management of Crohn's Disease After Surgical Resection. Gastroenterol Clin North Am. 2017 09; 46(3):563-575.
Singh S, Nguyen GC. PMID: 28838415.
View in: PubMed Mentions: 1 Fields: Translation: HumansPHPublic Health
-
Magnitude and Kinetics of Decrease in Liver Stiffness After Antiviral Therapy in Patients With Chronic Hepatitis C: A Systematic Review and Meta-analysis. Clin Gastroenterol Hepatol. 2018 Jan; 16(1):27-38.e4.
Singh S, Facciorusso A, Loomba R, Falck-Ytter YT. PMID: 28479504.
View in: PubMed Mentions: 21 Fields: Translation: Humans
-
Comparison of Infliximab and Adalimumab in Biologic-Naive Patients With Ulcerative Colitis: A Nationwide Danish Cohort Study. Clin Gastroenterol Hepatol. 2017 Aug; 15(8):1218-1225.e7.
Singh S, Andersen NN, Andersson M, Loftus EV, Jess T. PMID: 27913244.
View in: PubMed Mentions: 5 Fields: Translation: Humans
-
Comparative Effectiveness and Safety of Anti-Tumor Necrosis Factor Agents in Biologic-Naive Patients With Crohn's Disease. Clin Gastroenterol Hepatol. 2016 08; 14(8):1120-1129.e6.
Singh S, Heien HC, Sangaralingham LR, Schilz SR, Kappelman MD, Shah ND, Loftus EV. PMID: 27058635.
View in: PubMed Mentions: 12 Fields: Translation: Humans
-
Letter: faecal diversion for severe perianal Crohn's disease - practical issues. Authors' reply. Aliment Pharmacol Ther. 2015 Nov; 42(10):1237.
Singh S, Ding NS, . PMID: 26449866.
View in: PubMed Mentions: Fields: Translation: Humans
-
Comparative Effectiveness of Pharmacological Interventions for Severe Alcoholic Hepatitis: A Systematic Review and Network Meta-analysis. Gastroenterology. 2015 Oct; 149(4):958-70.e12.
Singh S, Murad MH, Chandar AK, Bongiorno CM, Singal AK, Atkinson SR, Thursz MR, Loomba R, Shah VH. PMID: 26091937.
View in: PubMed Mentions: 36 Fields: Translation: Humans
This graph shows the total number of publications by year. To see the data as text, click here.
This graph shows the total number of publications by year. To return to the graph, click here.
| Year | Publications |
|---|
| 2015 | 2 | | 2016 | 2 | | 2017 | 2 | | 2018 | 1 | | 2019 | 4 | | 2020 | 2 | | 2021 | 2 |
This graph shows the number and percent of publications by field.
Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications.
Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written.
To see the data as text, click here.
This graph shows the number and percent of publications by field.
Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications.
Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written.
To see the data as text, click here.
newest
oldest
line numbers
double spacing
all authors
publication IDs
|
Derived automatically from this person's publications.
_
People in Profiles who have published with this person.
_
People who share similar concepts with this person.
_
Search Department
_
|